MLK3 as a Regulator of Disease Progression in Non-Alcoholic Steatohepatitis

Liver International - United Kingdom
doi 10.1111/liv.12556
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

Dyslipidemia as a Risk Factor for Liver Fibrosis Progression in a Multicentric Population With Non-Alcoholic Steatohepatitis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2020English

Selective Aldosterone Blocker Ameliorates the Progression of Non-Alcoholic Steatohepatitis in Rats

International Journal of Molecular Medicine
MedicineGenetics
2010English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Portal Lymphadenopathy Predicts Non-Alcoholic Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease

PLoS ONE
Multidisciplinary
2018English

Modification of a Simple Clinical Scoring System as a Diagnostic Screening Tool for Non-Alcoholic Steatohepatitis in Japanese Patients With Non-Alcoholic Fatty Liver Disease

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Systematic Review: The Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2010English

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis

Clinics in Liver Disease
Hepatology
2009English

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

PLoS ONE
Multidisciplinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy